A three-pronged approach was followed for deducing the single cell genome sequencing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for single cell genome sequencing market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of single cell genome sequencing market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The single cell genome sequencing market was categorized into seven segments, namely product type (Instruments, Reagents), technology (NGS, PCR, qPCR, Microarray, MDA), workflow (Genomic Analysis, Single Cell Isolation, Sample Preparation), disease area (Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology), application (Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization), end-use (Academic & Research Laboratories, Biotechnology & Biopharmaceutical Companies, Clinics), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).
The single cell genome sequencing market was segmented into product type, technology, workflow, disease area, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The single cell genome sequencing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The single cell genome sequencing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Fluidigm Corporation - The publicly traded Fluidigm Corporation creates and produces equipment for biological research. Additionally, it creates devices using Integrated Fluidic Circuit (IFC) technology. The solutions offered by Fluidigm include hardware, software, high-performance genotyping, and gene expression tests, as well as primers for sample preparation for next-generation sequencing. The company now conducts business in MEA, Asia Pacific, Latin America, North America, and Germany.
QIAGEN - Assay technologies are developed by QIAGEN for use in pharmaceuticals, life science research, applied testing, and molecular diagnostics. Moreover, the company's molecular technologies are being used by forensic professionals. The firm works with biological samples to separate genetic material. The business has operations in more than 25 nations.
Illumina, Inc. - Publicly traded, Illumina, Inc. is a producer of instruments for gene isolation and analysis. The firm sells tools and software for sequencing RNA and DNA. Additionally, the company offers an array of genomic research tools. Illumina serves a broad spectrum of businesses in the biotechnology and pharmaceutical industries, as well as research & educational establishments. At the moment, the business is active in Latin America, MEA, Asia Pacific, North America, and Germany.
F. Hoffmann-La Roche Ltd. - The primary activities of F. Hoffmann-La Roche Ltd. are the creation and distribution of pharmaceutical and diagnostic products to aid healthcare and research organizations. It has around 22 R&D and 26 production locations worldwide. It is divided into two segments: diagnostics and medications. The pharmaceutical industry produces medications for a range of infections, cancer, metabolic problems, autoimmune illnesses, cardiovascular and respiratory conditions, and metabolic disorders. It maintains strategic alliances with several organizations across about 150 nations, including the United States and Japan.
Thermo Fisher Scientific Inc. - Thermo Fisher Scientific Inc. is a publicly traded corporation that creates, produces, and sells laboratory supplies, apparatus, consumables, and analytical tools for use in biological and medical research, illness diagnosis, and the development of new drugs and vaccines. Thermo Electron and Fisher Scientific merged to form the firm. It uses names like Fisher Scientific, Invitrogen, Thermo Scientific, Applied Biosystems, and Unity Lab Services to conduct business. The business's analytical instrument sector offers services, consumables, and equipment for use in agricultural, laboratory, and production line settings.
Bio-Rad Laboratories, Inc. - Products for clinical diagnostics, food science, spectroscopy, process separations, and life science research are produced and supplied by Bio-Rad Laboratories, Inc. Clinical diagnostics and life science are two of Bio-Rad's business segments. The life science sector creates, produces, and distributes chemicals, equipment, and tools for use in clinical trials, food safety protocols, and other applications. In addition, the business's clinical diagnostics division produces, markets, and provides support for test kits, test systems, specific quality controls, and informatics solutions for clinical labs in the diagnostics industry. Additionally, it offers its clients an On-Site Supply Center. The business operates in 34 different nations.
10x Genomics, Inc. - 10x Genomics, Inc. is a publicly traded firm that provides DNA sequencing technologies. The firm offers products for single-cell genomics, De novo assembly, single-cell V(D)J, whole exome sequencing, and whole genome sequencing. The firm now has operations in Latin America, Asia Pacific, North America, Germany, and MEA.
BD - The publicly traded corporation Becton, Dickinson, and Company (BD) is divided into three business segments: BD Medical, BD Life Sciences, and BD Biosciences. The company's areas of expertise include medication delivery systems, genomics, infection control, and microbiology solutions. It has 20 brands and offers a range of integrated healthcare solutions. At the moment, the business is active in over 190 nations, including Germany, the Middle East & Africa, Asia Pacific, Latin America, and North America.
Oxford Nanopore Technologies - Oxford Nanopore Technologies is a privately held firm that develops and markets devices for single molecule analysis using nanopore sequencing. Additionally, the business offers advanced training in the field of genetics and hosts workshops. Human genetics, cancer research, population genomics, transcriptome analysis, microbiology, and clinical, plant, and environmental research are just a few of the disciplines for which the company offers goods and services. There are no subsidiaries for the company. The company now conducts business in Germany, Asia Pacific, and North America.
BGI - Next-generation sequencing services and products are offered by BGI, a non-public firm, to medical and scientific institutions as well as other public and commercial organizations operating in the same sector. The business was once called Beijing Genomics Institute. Currently, the business is active in over 100 nations across several continents, such as Asia Pacific, Germany, and North America. Presently, the organization collaborates with over 300 hospitals and over 3,000 medical facilities.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member